How Much Weight Can You Lose on Ozempic or a GLP-1 Drug
Advantage : Bioglutide Weight Loss Efficacy# Bioglutide : Phase 2 showed 14.8% mean weight loss at 150 mg at 13 weeks (13.2% placebo-adjusted)
So when they looked at age, baseline weight, type two diabetes, behavioral support, dietician support, that didn't have an impact, so accounting for all of that, the people in hormone replacement therapy still had better intended outcomes, which the intention was to lose weight
GLP-1 Receptor Agonist Market Size, Share & Trends Analysis Report By Product (Semaglutide, Tirzepatide, Dulaglutide, Liraglutide, Others), By Application (Type 2 Diabetes Mellitus, Chronic Weight Management, Cardiovascular Risk Reduction, Others), By Route of Administration (Parenteral, Oral), By Distribution Channel (Hospital Pharmacies, Drug Stores & Retail Pharmacies, Online Pharmacies) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034 Last Updated: July 17, 2026 | Author: Pavan Warade | Format: | Report Code: SR8134DR | Pages: 200 GLP-1 Receptor Agonist Market Size & Growth Analysis The GLP-1 receptor agonist market size was valued at USD 56.34 billion in 2025 and is projected to grow from USD 63.24 billion in 2026 to USD 161.40 billion by 2034, registering a CAGR of 12.43% during the forecast period (20262034)
